Lexeo Therapeutics (LXEO) Return on Sales (2022 - 2023)
Historic Return on Sales for Lexeo Therapeutics (LXEO) over the last 2 years, with Q4 2023 value amounting to 283.74%.
- Lexeo Therapeutics' Return on Sales changed N/A to 283.74% in Q4 2023 from the same period last year, while for Dec 2023 it was 323.87%, marking a year-over-year change of. This contributed to the annual value of 717.76% for FY2024, which is 3938900.0% up from last year.
- As of Q4 2023, Lexeo Therapeutics' Return on Sales stood at 283.74%.
- Over the past 5 years, Lexeo Therapeutics' Return on Sales peaked at 386.69% during Q3 2023, and registered a low of 32.12% during Q3 2022.